These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 11084063)
21. Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcome. Wiesner RH; Porayko MK; Hay JE; LaRusso NF; Steers JL; Krom RA; Dickson ER Liver Transpl Surg; 1996 Sep; 2(5 Suppl 1):99-108. PubMed ID: 9346709 [TBL] [Abstract][Full Text] [Related]
22. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304 [TBL] [Abstract][Full Text] [Related]
23. Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis. Boberg KM; Rocca G; Egeland T; Bergquist A; Broomé U; Caballeria L; Chapman R; Hultcrantz R; Mitchell S; Pares A; Rosina F; Schrumpf E Hepatology; 2002 Mar; 35(3):652-7. PubMed ID: 11870380 [TBL] [Abstract][Full Text] [Related]
24. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. Befeler AS; Palmer DE; Hoffman M; Longo W; Solomon H; Di Bisceglie AM Arch Surg; 2005 Jul; 140(7):650-4; discussion 655. PubMed ID: 16027329 [TBL] [Abstract][Full Text] [Related]
25. A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation. Xu X; Ling Q; Wu J; Chen J; Gao F; Feng XN; Zheng SS Liver Int; 2007 Aug; 27(6):816-24. PubMed ID: 17617125 [TBL] [Abstract][Full Text] [Related]
26. Comparative assessment of prognostic value for revised-Mayo risk model and Child-Pugh score in patients with primary sclerosing cholangitis. Öztaş E; Özer Etik D; Metin RO; Kalkan İH; Parlak E; Önder FO; Arhan M; Şaşmaz N Turk J Gastroenterol; 2015 Jan; 26(1):31-5. PubMed ID: 25698268 [TBL] [Abstract][Full Text] [Related]
27. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis. Tanaka A; Takamori Y; Toda G; Ohnishi S; Takikawa H Liver Int; 2008 Aug; 28(7):983-9. PubMed ID: 18397233 [TBL] [Abstract][Full Text] [Related]
29. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease. Wiesner RH Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):667-80. PubMed ID: 11492975 [TBL] [Abstract][Full Text] [Related]
30. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Graziadei IW; Wiesner RH; Marotta PJ; Porayko MK; Hay JE; Charlton MR; Poterucha JJ; Rosen CB; Gores GJ; LaRusso NF; Krom RA Hepatology; 1999 Nov; 30(5):1121-7. PubMed ID: 10534330 [TBL] [Abstract][Full Text] [Related]
31. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis. Navaneethan U; Venkatesh PG; Lashner BA; Shen B; Kiran RP Aliment Pharmacol Ther; 2012 May; 35(9):1045-53. PubMed ID: 22428605 [TBL] [Abstract][Full Text] [Related]
32. Predicting outcome of transplantation for cholestatic liver disease: Child-Pugh or Mayo risk score? Brown RS Liver Transpl; 2000 Nov; 6(6):759-61. PubMed ID: 11084064 [No Abstract] [Full Text] [Related]
33. Primary sclerosing cholangitis in children: a long-term follow-up study. Feldstein AE; Perrault J; El-Youssif M; Lindor KD; Freese DK; Angulo P Hepatology; 2003 Jul; 38(1):210-7. PubMed ID: 12830004 [TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis. Karlsen TH; Lie BA; Frey Frøslie K; Thorsby E; Broomé U; Schrumpf E; Boberg KM Gastroenterology; 2006 Sep; 131(3):781-7. PubMed ID: 16952547 [TBL] [Abstract][Full Text] [Related]
35. Mortality and length-of-stay outcomes, 1993-2003, in the binational Australian and New Zealand intensive care adult patient database. Moran JL; Bristow P; Solomon PJ; George C; Hart GK; Crit Care Med; 2008 Jan; 36(1):46-61. PubMed ID: 18090383 [TBL] [Abstract][Full Text] [Related]
36. Recurrence of primary sclerosing cholangitis in patients after liver transplantation. Ołdakowska-Jedynak U; Nowak M; Mucha K; Foroncewicz B; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Patkowski W; Górnicka B; Paczkowska A; Michałowicz B; Pilecki T; Pawlak J; Krawczyk M; Paczek L Transplant Proc; 2006; 38(1):240-3. PubMed ID: 16504713 [TBL] [Abstract][Full Text] [Related]
38. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Brown RS; Kumar KS; Russo MW; Kinkhabwala M; Rudow DL; Harren P; Lobritto S; Emond JC Liver Transpl; 2002 Mar; 8(3):278-84. PubMed ID: 11910574 [TBL] [Abstract][Full Text] [Related]
39. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Kugelmas M; Spiegelman P; Osgood MJ; Young DA; Trotter JF; Steinberg T; Wachs ME; Bak T; Kam I; Everson GT Liver Transpl; 2003 Jul; 9(7):727-32. PubMed ID: 12827560 [TBL] [Abstract][Full Text] [Related]
40. Factors that predict survival in patients with cirrhosis considered for liver transplantation. Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]